Yk. Oh et Ja. Swanson, DIFFERENT FATES OF PHAGOCYTOSED PARTICLES AFTER DELIVERY INTO MACROPHAGE LYSOSOMES, The Journal of cell biology, 132(4), 1996, pp. 585-593
Phagocytosis in macrophages is often studied using inert polymer micro
spheres. An implicit assumption in these studies is that such particle
s contain little or no specific information in their structure that af
fects their intracellular fate. We tested that assumption by examining
macrophage phagosomes containing different kinds of particles and fou
nd that although all particles progressed directly to lysosomes, their
subsequent fates varied. Within 15 min of phagocytosis, >90% of phago
somes containing opsonized sheep erythrocytes, poly-e-caprolactone mic
rospheres, polystyrene microspheres (PS), or polyethylene glycol-conju
gated PS merged with the lysosomal compartment. After that point, howe
ver, the characteristics of phagolysosomes changed in several ways tha
t indicated differing degrees of continued interaction with the lysoso
mal compartment. Sheep erythrocyte phagolysosomes merged together and
degraded their contents quickly, poly-e-caprolactone phagolysosomes sh
owed intermediate levels of interaction, and PS phagolysosomes became
isolated within the cytoplasm. PS were relatively inaccessible to an e
ndocytic tracer, Texas red dextran, added after phagocytosis. Moreover
, immunofluorescent staining for the lysosomal protease cathepsin L de
creased in PS phagolysosomes to 23% by 4 h after phagocytosis, indicat
ing degradation of the enzyme without replacement. Finally, PS surface
labeled with fluorescein-labeled albumin showed a markedly reduced ra
te of protein degradation in phagolysosomes, when compared to rates me
asured for proteins in or on other particles. Thus, particle chemistry
affected both the degree of postlysosomal interactions with other org
anelles and, consequently, the intracellular half-life of particle-ass
ociated proteins. Such properties may affect the ability of particles
to deliver macromolecules into the major histocompatibility complex cl
ass I and II antigen presentation pathways.